|Comment on T-1249
Feb 10, 2004
I am a little disappointed to hear that Trimeris is discontinuing its development of T-1249. Supposedly this drug would be effective against resistent virus to T-20. From what I understand their reason is simply because T-20 has failed to generate alot of sales/profits. It just seems that if a product is known to benefit sick people they shold be forced to produce it. My question is... What can I do to fight against unjustices such as this.
| Response from Dr. Wohl
Thanks for sharing your concern with us. The company states that they had hoped that T-1249 would be administered less frequently than it is but that has not worked out. There are also issues with production.
I suggest you ask them about these statements and express your dissatisfaction by writing or emailing Roche, the parent company. Find the addresses relevant to where you live at www.roche.com.
Get Email Notifications When This Forum Updates or Subscribe With RSS
This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.
Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.